CSIG-12. BXQ-350 INDUCES MITOPHAGY IN GBM CELLS LEADING TO CELL DEATH. (14th November 2022)
- Record Type:
- Journal Article
- Title:
- CSIG-12. BXQ-350 INDUCES MITOPHAGY IN GBM CELLS LEADING TO CELL DEATH. (14th November 2022)
- Main Title:
- CSIG-12. BXQ-350 INDUCES MITOPHAGY IN GBM CELLS LEADING TO CELL DEATH
- Authors:
- Wilkins, Nikhil
Furnish, Robin
Stephens, Tim - Abstract:
- Abstract: BACKGROUND: Mitophagy is an autophagic phenomenon where defective mitochondria are selectively degraded. When mitochondria need recycling, the cell upregulates the production of the lipid C-18 ceramide on the mitochondria and lipoprotein LC3B-II on the lysosome, which transitions to an autophagolysosome. This creates a signal causing the degradation of mitochondria. Here we show that BXQ-350, a novel protein-lipid small molecule consisting of the ceramide creating protein Saposin C and the lipid Dioleoyl Phosphatidylserine (DOPS), induces glioblastoma cells into performing mitophagy. Increased production of mitophagy associated proteins, C-18, and LC3B-II leads to the degradation of healthy mitochondria followed by cell death. METHODS: The GBM cell lines, Gli36 and U87 cells, were used to determine if increased mitophagy was occurring in response to BXQ-350 treatment. Protein abundance was measured using SILAC proteomics. Ceramide levels were analyzed using LC/MS-MS. Western Blot analysis was used to measure differences in LC3B-II levels. Mitophagy was measured using Mtphagy Dye from Dojindo and the BioTek Cytation 5 microscope. RESULTS: Proteomics showed cells treated with BXQ-350 had an increase in proteins associated with overexpression of C-18 ceramide or autophagolysosome maturation. Western blots analysis showed a marked increase in LC3B-II in BXQ-350 treated cells. Furthermore, cells treated with BXQ-350 had increased levels of C-18 ceramide. The Mtphagy dyeAbstract: BACKGROUND: Mitophagy is an autophagic phenomenon where defective mitochondria are selectively degraded. When mitochondria need recycling, the cell upregulates the production of the lipid C-18 ceramide on the mitochondria and lipoprotein LC3B-II on the lysosome, which transitions to an autophagolysosome. This creates a signal causing the degradation of mitochondria. Here we show that BXQ-350, a novel protein-lipid small molecule consisting of the ceramide creating protein Saposin C and the lipid Dioleoyl Phosphatidylserine (DOPS), induces glioblastoma cells into performing mitophagy. Increased production of mitophagy associated proteins, C-18, and LC3B-II leads to the degradation of healthy mitochondria followed by cell death. METHODS: The GBM cell lines, Gli36 and U87 cells, were used to determine if increased mitophagy was occurring in response to BXQ-350 treatment. Protein abundance was measured using SILAC proteomics. Ceramide levels were analyzed using LC/MS-MS. Western Blot analysis was used to measure differences in LC3B-II levels. Mitophagy was measured using Mtphagy Dye from Dojindo and the BioTek Cytation 5 microscope. RESULTS: Proteomics showed cells treated with BXQ-350 had an increase in proteins associated with overexpression of C-18 ceramide or autophagolysosome maturation. Western blots analysis showed a marked increase in LC3B-II in BXQ-350 treated cells. Furthermore, cells treated with BXQ-350 had increased levels of C-18 ceramide. The Mtphagy dye showed that as BXQ-350 concentrations increased, the percentage of cells positive for Mitophagy increased. To determine if mitophagy occurs in association with BXQ-350 cytotoxicity, medias with varying BXQ-350 cytotoxicity were used. The Mtphagy dye showed cytotoxic BXQ-350 medias increased levels of mitophagy, while noncytotoxic medias display no increase in mitophagy. CONCLUSION: BXQ-350 causes the increase of mitophagy signaling proteins, C-18 ceramide and LC3B-II production, resulting in the formation of autophagolysosomes which track towards the mitochondria initiating mitophagy. This leads to aberrant mitophagy where cells degrade healthy mitochondria leading to mitophagic cell death. … (more)
- Is Part Of:
- Neuro-oncology. Volume 24(2022)Supplement 7
- Journal:
- Neuro-oncology
- Issue:
- Volume 24(2022)Supplement 7
- Issue Display:
- Volume 24, Issue 7 (2022)
- Year:
- 2022
- Volume:
- 24
- Issue:
- 7
- Issue Sort Value:
- 2022-0024-0007-0000
- Page Start:
- vii41
- Page End:
- vii41
- Publication Date:
- 2022-11-14
- Subjects:
- Brain Neoplasms -- Periodicals
Brain -- Tumors -- Periodicals
Brain -- Cancer -- Periodicals
Nervous system -- Cancer -- Periodicals
616.99481 - Journal URLs:
- http://neuro-oncology.dukejournals.org/ ↗
http://neuro-oncology.oxfordjournals.org/ ↗
http://www.oxfordjournals.org/content?genre=journal&issn=1522-8517 ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/neuonc/noac209.161 ↗
- Languages:
- English
- ISSNs:
- 1522-8517
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6081.288000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24558.xml